Rita Redberg, MD, FACC, MSc, is Professor of Medicine at the University of California, San Francisco.She is the editor of JAMA Internal Medicine but was not involved in decisions regarding review or acceptance of the manuscript.Moreover, she is highly credible and is viewed as an authority on a number of health policy issues.
Events - Primer's event detection algorithm clusters and summarizes multiple documents describing real-world events.
Mentions - Mentions are snippets of text that map to a person.
Docs - The number of documents that match to a person in Primer's corpus of news articles.
Full tech explainer here.
To update Wikipedia with this information, visit the page for the subject above.
the University of California, San Francisco
The Atlantic crunched the numbers and reported the discrepancy in care means 32,000 fewer Medicare patients alone would die every year if they had women doctors — or, as the outlet wrote, "male physicians were as adept as females." Physicians Rita Redberg and Anna Parks used the findings as the basis for their editorial, arguing it's time female doctors received the same pay as their male colleagues. According to their article, female academic physicians make about $19,879 — or 8% — less than male physicians on average.
Cardiologists say the popular belief saturated fat can clog up arteries is ‘plain wrong’ Cheese, pizza and burgers - they’re all high in saturated fats but may not be as bad for you as you thought. “It is time to shift the public health message in the prevention and treatment of coronary artery disease away from measuring serum lipids and reducing dietary saturated fat,” an editorial in the journal says. Cardiologists Dr Aseem Malhotra, Professor Rita Redberg and Pascal Meier cite evidence showing no association between consumption of saturated fat and heightened risk of cardiovascular disease, diabetes and death. “Coronary artery disease is a chronic inflammatory disease and it can be reduced effectively by walking 22 minutes a day and eating real food,” they write.
Many drugs granted accelerated approval by the U.S. Food and Drug Administration lack clear evidence of safety and effectiveness, and the same is true for most high-risk medical devices, according to two new reports in the Journal of the American Medical Association. For standard approval, the FDA generally requires gold-standard randomized controlled trials that demonstrate a drug’s safety and effectiveness. “Our findings suggest that expediency in drug development and approval can be successful but that drugs approved via the shorter route to market are rarely subject to tests even in the post-approval period that use established and clinically meaningful outcomes,” Naci said. When the FDA approves medicines via its Accelerated Approval pathway, he said, the agency should clearly specify the data limitations and how required confirmatory studies are expected to compensate for these limitations. “I think the public assumes that medical devices currently on the market, particularly high-risk devices, have been approved based on a high standard to show safety and effectiveness before doctors can recommend and implant them,” Redberg said.